Thermo Fisher: stake buy and hiring signals

A small hedge fund stake and a fresh artificial intelligence hiring push in Bengaluru are adding to the latest read on Thermo Fisher Scientific’s direction in 2026. (sec.gov) Castellan Group disclosed a new Thermo Fisher position in its Form 13F filing for the quarter ended December 31, 2025, with outside summaries putting the investment at about $2.11 million. Form 13F reports show what larger money managers held at quarter-end, not why they bought. (sec.gov, defenseworld.net) Thermo Fisher is also advertising an “AI Application Developer” role in Bangalore, Karnataka, on its own careers site, alongside a separate “Sr. Developer - AI & Automation” opening in the same city. The company groups those jobs under “IT, Data & Tech,” its internal category for software, analytics and digital work. (jobs.thermofisher.com, jobs.thermofisher.com) Thermo Fisher sells lab instruments, diagnostics and drug-development services, and it has been expanding the software layer around those businesses. In its January 29, 2026 earnings release, the company said it had established a strategic collaboration with OpenAI to expand artificial intelligence across operations, products and services. (ir.thermofisher.com) That same earnings report showed a business still growing at scale: fourth-quarter 2025 revenue rose 7% to $12.21 billion, and full-year revenue increased 4% to $44.56 billion. Thermo Fisher also said it deployed about $16.5 billion in capital during 2025. (ir.thermofisher.com) The hiring matters because Thermo Fisher is not pitching artificial intelligence as a side project. Its careers page says data science, digital and information technology roles are meant to support the company’s core mission across research, diagnostics and laboratory operations. (jobs.thermofisher.com) The investment filing matters for a different reason: it shows Thermo Fisher remains on institutional investors’ shopping lists even when the disclosed position is modest relative to the company’s size. Thermo Fisher’s latest annual report describes the company as generating more than $40 billion in annual revenue and trading on the New York Stock Exchange under the ticker TMO. (ir.thermofisher.com, sec.gov) Taken together, the new stake and the Bengaluru openings point to the same near-term story: Thermo Fisher is still attracting portfolio capital while building more software and automation capacity inside a lab-tools giant. (sec.gov, jobs.thermofisher.com, ir.thermofisher.com)